CLDI Award Disclosure
Jackson Andrew C. · SEC Form 4 · Filed Aug 19, 2026
Award
Reported value range
Not reported
Jackson Andrew C. Chief Financial Officer
CLDI
Transaction date
Aug 17, 2026
Public filing date
Aug 19, 2026
Filing lag
Filed 2 days later
CLDI daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Options (right to buy) on Common stock
- Quantity / price
- 14,000 shares
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001493152-26-039289
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Calidi Biotherapeutics, Inc. CLDI Current | Award | Aug 17, 2026 | Not reported |